Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

Clinical trial NCT01896180 · COMPLETED

Trial details

NCT number: NCT01896180
Sponsor: Alleanza Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma Ocular Hypertension Elevated Intraocular Pressure

Start date: 2013-07-01
Primary completion: 2014-01-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.